Good news about AIDS

[Chris]

San Diego, California (CNN) -- Antiretroviral drugs that are being used to prolong the lives of patients infected with HIV/AIDS could also be greatly effective in slowing its spread, epidemiologist Brian Williams said.

The concentration of the virus drops by a factor of 10,000 with antiretroviral treatment, resulting in 25 times the reduction of infectiousness, said Williams, formerly of the World Health Organization and now at the South African Centre for Epidemiological Modelling and Analysis. That means that if more people with HIV received this therapy early, there would be fewer new cases of the disease, he said Saturday at the annual meeting of the American Association for the Advancement of Science.

"We could effectively stop transmission within five years," Williams said.
About 33 million people are living with HIV, according to 2008 estimates by the World Health Organization and UNAIDS. That year, 2 million people died of AIDS and 2.7 became newly infected.

Expert: Using antiretroviral drugs early may curb HIV/AIDS spread - CNN.com

 

[RadiomanATL]

Good news about AIDS

Yukon has it

 

[Big Black Dog]

I used to have AIDS but I had to lay both of them off when I retired.

 

[Harry Dresden]

Good news about AIDS

Yukon has it

no that would be bad news.....he then would infect,or has infected, all those young boys he chases.....

 

[lucia91]

definitely great news, please scientist work hard

 

[waltky]

Kick and Kill protocol shows promise for AIDS cure...

Clinical Results Show Promise in Search for HIV Cure
October 03, 2016 - A promising multi-disciplinary approach to fighting HIV has led to an encouraging first set of results from clinical trials. The new treatment — called Kick and Kill — comes out of a collaboration between five leading U.K. research establishments.

Waking up sleeping HIV cells

The therapy targets people diagnosed with HIV who are taking antiretroviral therapy (ART) drugs. ART drugs reduce the amount of HIV in the bloodstream to such small levels that patients can't pass along the virus and their immune system is able to fight it. The problem is that HIV is incredibly sneaky, and ART alone can't "cure" it. A news release from the U.K. National Institute of Health Research (NHS) explains it this way: ART "only works on HIV infected cells that are active, and most cells infected with HIV in the human body contain resting or sleeping virus."

Ruth Munyao, a pharmacist, dispenses antiretroviral drugs at the Mater Hospital in Kenya's capital of Nairobi​

And that's where the idea of Kick and Kill comes in. The treatment consisted of giving HIV patients a drug called an HDAC inhibitor, which is commonly used to fight cancer. In HIV-positive people, HDAC is the enzyme that allows these dormant HIV cells to rest. Tamping down HDAC "kicks" the virus awake. Once awake, the ART therapy can kill even more of the virus, and could ultimately lead to a cure.

More results ahead

Researchers plan to try the new therapy on 50 HIV study participants. "This first participant has now completed the intervention and we have found it to be safe and well tolerated," said Sarah Fidler, professor of HIV and Communicable Diseases at Imperial College London and co-principal investigator on the study. "Only when all 50 study participants have completed the whole study, by 2018, will we be able to tell if there has been an effect on curing HIV."

In a news release Monday, the NHS urged caution on reporting the study, saying "all participants involved in the study will be expected to have no HIV in their blood because they are receiving antiretroviral therapy — these are the standard drugs we use to treat HIV."

Clinical Results Show Promise in Search for HIV Cure

 

[DGS49]

The good thing about AIDS is that it is ENTIRELY preventable. The bad news is that the general public is forced to pay the enormous cost of treatment and research - for a disease that is (did I mention this before?) entirely preventable.

 

[waltky]

A bid to avert new infections...

Kenya to Roll Out Drug to Curb HIV Infection
March 17, 2017 — Thousands of HIV-negative Kenyans will for the first time be placed on daily antiretroviral medication, or ARVs, in a bid to avert new infections. The new program seeks to lower the country's HIV transmission rate to individuals who face a substantial risk of contracting HIV, such as rape victims and HIV-negative drug users.

The head of the National AIDS and STI Control Program (NASCOP), Martin Sirengo, said the measure will be rolled out in April and will involve the use of Pre-exposure Prophylaxis, or PrEP. “We are introducing PrEP to a selected population, not to everyone, and this selected population includes, for instance, HIV-negative partners in a discordant relationship, where the other partner is positive,” Sirengo said. “Anyone who comes and gives a history of repeated sexually transmitted infections, anyone who comes for repeated PrEP medication, that tells us they are at risk of getting HIV," will be eligible, he said. "We are also recommending PrEP to anyone who has multiple sexual partners.”

Drugs are very effective

If taken daily, the drugs have a success rate of preventing HIV infection of more than 96 percent, according to pilot studies conducted in Kenya by NASCOP and the Partners Prevention Program between 2013 and 2016. “Only four out of the over 1,500 [tested] got infected [with] HIV, which means prep is highly effective to the tune of over 96 percent or more,” Sirengo said. “And, when we look at the four that got positive, we actually realized they were not adhering to the treatment.” Kenya becomes the second country in Africa, after South Africa, to roll out PrEP. However, it is widely used in developed countries.

Some aren't so sure

Some are still skeptical about the drug. Esther Atieno is a commercial sex worker. She says she prefers to use alternative methods. “I don't think many people will use it,” Atieno said. “There is no one who likes to take medication every day. The condom is the best protective method because it is not something you use every day like the daily pill.”

Drugs free in public facilities

Sirengo agrees that users should combine PrEP with other preventive interventions, like use of condoms and male circumcision to further reduce the risk of acquiring HIV. The cost of the treatment is between $500 to $800 a person per year, but it is expected NGOs and other partners will subsidize the treatment.

Post-exposure prophylaxis requires taking antiretroviral medicines after being potentially exposed to HIV to prevent becoming infected. The drugs can prevent HIV infection by more than 96 percent​

The drugs will be free in all public facilities, but those who seek treatment in private health facilities will have to purchase the drugs for $60-$100 per annual treatment. Sirengo says trained health workers will assess who qualifies for this treatment. It is anticipated that the drug will avert many new infections in Kenya, reported to have the fourth-highest HIV infection in the world. An estimated 1.5 million Kenyans are said to be living with the virus.

Kenya to Roll Out Drug to Curb HIV Infection

 

[yiostheoy]

San Diego, California (CNN) -- Antiretroviral drugs that are being used to prolong the lives of patients infected with HIV/AIDS could also be greatly effective in slowing its spread, epidemiologist Brian Williams said.

The concentration of the virus drops by a factor of 10,000 with antiretroviral treatment, resulting in 25 times the reduction of infectiousness, said Williams, formerly of the World Health Organization and now at the South African Centre for Epidemiological Modelling and Analysis. That means that if more people with HIV received this therapy early, there would be fewer new cases of the disease, he said Saturday at the annual meeting of the American Association for the Advancement of Science.

"We could effectively stop transmission within five years," Williams said.
About 33 million people are living with HIV, according to 2008 estimates by the World Health Organization and UNAIDS. That year, 2 million people died of AIDS and 2.7 became newly infected.

Expert: Using antiretroviral drugs early may curb HIV/AIDS spread - CNN.com

The only way to stop the spread of AIDS is put a condom on your d!ck.

Anyone not smart enough to open a pack of condoms is going to die.

The Hershey Bar Road is a nasty place anyway.

Anybody not smart enough to wear a condom on that road is going to die.

The only way to avoid AIDS is get blood tests before you fokk each other.

Then don't fokk anybody else.

This used to be called fidelity.

Now it can save your life.

 

[yiostheoy]

A bid to avert new infections...

Kenya to Roll Out Drug to Curb HIV Infection
March 17, 2017 — Thousands of HIV-negative Kenyans will for the first time be placed on daily antiretroviral medication, or ARVs, in a bid to avert new infections. The new program seeks to lower the country's HIV transmission rate to individuals who face a substantial risk of contracting HIV, such as rape victims and HIV-negative drug users.

The head of the National AIDS and STI Control Program (NASCOP), Martin Sirengo, said the measure will be rolled out in April and will involve the use of Pre-exposure Prophylaxis, or PrEP. “We are introducing PrEP to a selected population, not to everyone, and this selected population includes, for instance, HIV-negative partners in a discordant relationship, where the other partner is positive,” Sirengo said. “Anyone who comes and gives a history of repeated sexually transmitted infections, anyone who comes for repeated PrEP medication, that tells us they are at risk of getting HIV," will be eligible, he said. "We are also recommending PrEP to anyone who has multiple sexual partners.”

Drugs are very effective

If taken daily, the drugs have a success rate of preventing HIV infection of more than 96 percent, according to pilot studies conducted in Kenya by NASCOP and the Partners Prevention Program between 2013 and 2016. “Only four out of the over 1,500 [tested] got infected [with] HIV, which means prep is highly effective to the tune of over 96 percent or more,” Sirengo said. “And, when we look at the four that got positive, we actually realized they were not adhering to the treatment.” Kenya becomes the second country in Africa, after South Africa, to roll out PrEP. However, it is widely used in developed countries.

Some aren't so sure

Some are still skeptical about the drug. Esther Atieno is a commercial sex worker. She says she prefers to use alternative methods. “I don't think many people will use it,” Atieno said. “There is no one who likes to take medication every day. The condom is the best protective method because it is not something you use every day like the daily pill.”

Drugs free in public facilities

Sirengo agrees that users should combine PrEP with other preventive interventions, like use of condoms and male circumcision to further reduce the risk of acquiring HIV. The cost of the treatment is between $500 to $800 a person per year, but it is expected NGOs and other partners will subsidize the treatment.

Post-exposure prophylaxis requires taking antiretroviral medicines after being potentially exposed to HIV to prevent becoming infected. The drugs can prevent HIV infection by more than 96 percent​

The drugs will be free in all public facilities, but those who seek treatment in private health facilities will have to purchase the drugs for $60-$100 per annual treatment. Sirengo says trained health workers will assess who qualifies for this treatment. It is anticipated that the drug will avert many new infections in Kenya, reported to have the fourth-highest HIV infection in the world. An estimated 1.5 million Kenyans are said to be living with the virus.

Kenya to Roll Out Drug to Curb HIV Infection

So why did you bounce this ??

 

[waltky]

Was playin' bouncy-ball...

... with possum.

 

[yiostheoy]

There is nothing new about AIDS.

Every time I see Ervil Magic Johnson I wonder how he manages to hang on for so long.

He claims to have caught it from a female.

That is almost impossible to do.

You catch AIDS by opening up your own Hershey Bar Road to traffic.

Anyone stupid enough to do that without condom use is going to die.

 

[heil hitler]

You're damn correct. This whole Hetero myth was created by scat eating sodomite, GRIDS patients to gain the sympathy...AND FUNDING from the mainstream for Gay Cancer research.

 

[yiostheoy]

You're damn correct. This whole Hetero myth was created by scat eating sodomite, GRIDS patients to gain the sympathy...AND FUNDING from the mainstream for Gay Cancer research.

Hetero infection happens from girlies opening up their own Hershey Bar Road to bi males, apparently. This is the theory of the disease.

Apparently the Hershey Bar Road is the main conduit of infection sexually. Although guzzling a big load of infected semen cannot be a good thing either.

Guzzling a load of vaginal secretions from an infected female cannot be a good thing either.

We actually need more research on the habits of these infected people to figure out how they got it. And no lying.

 

[waltky]

Experimental Vaccine Against HIV Looks Hopeful...

Experimental Vaccine Against HIV has Promising Results
Tuesday 25th July, 2017 - A study on a HIV vaccine, which is still at an early stage, has given encouraging results. It was presented at an international conference on AIDS research in Paris. Reports ChronicleBG.

After being tested on 393 volunteers from 5 countries - the United States, Rwanda, Uganda, South Korea and Thailand, the vaccine prototype caused an immune response - antibody production in all participants. "These promising results, as well as the success of other scientists in the same field, encourage us to be optimistic about the development of the HIV vaccine," said Dan Baruh of the research team.

Experts believe that the vaccine remains the best way to put an end to an epidemic that infected 76 million people and caused 35 million deaths since its appearance in the early 1980s. According to the United Nations Program on HIV / AIDS, despite the prevention methods, 1.8 million new infections were registered in 2016. "So far, only four vaccine projects have tested their clinical efficacy," reminded the virologist Dan Baruh of Harvard University.

The experimental vaccine first excites the immune system with the help of a rhinovirus before it stimulates it with a protein found on the HIV structure, triggering a stronger response from the body. "In a previous phase of the monkey study, this strategy prevented the spread of the infection among two-thirds of the animals," Baruh said. "Of course, we still do not know if the vaccine will protect people, but the results obtained justify carrying out larger-scale research."

Experimental Vaccine Against HIV has Promising Results